Other aplastic anemias and other bone marrow failure syndromes (D61) ICD-10-CM
The D61 code range covers other aplastic anemias and other bone marrow failure syndromes with 17 ICD-10-CM diagnosis codes. 13 of them are billable and valid for claim submission in fiscal year 2027, and the category headers group them but cannot themselves be billed.
Type 2 Excludes
A type 2 excludes note represents "Not included here". An excludes2 note indicates that the condition excluded is not part of the condition represented by the code, but a patient may have both conditions at the same time. When an Excludes2 note appears under a code, it is acceptable to use both the code and the excluded code together, when appropriate.
- neutropenia D70
Codes in the D61 Range 17 codes · 13 billable
- D61 Other aplastic anemias and other bone marrow failure syndromesNon-billable
- D61.0 Constitutional aplastic anemiaNon-billable
- D61.01 Constitutional (pure) red blood cell aplasia
- D61.02 Shwachman-Diamond syndrome
- D61.03 Fanconi anemia
- D61.09 Other constitutional aplastic anemia
- D61.1 Drug-induced aplastic anemia
- D61.2 Aplastic anemia due to other external agents
- D61.3 Idiopathic aplastic anemia
- D61.8 Other specified aplastic anemias and other bone marrow failure syndromesNon-billable
- D61.81 PancytopeniaNon-billable
- D61.810 Antineoplastic chemotherapy induced pancytopenia
- D61.811 Other drug-induced pancytopenia
- D61.818 Other pancytopenia
- D61.82 Myelophthisis
- D61.89 Other specified aplastic anemias and other bone marrow failure syndromes
- D61.9 Aplastic anemia, unspecified
Clinical Terms in This Code Range
Definitions from the National Library of Medicine for conditions coded in the D61 range.
Anemia, Aplastic
A form of anemia in which the bone marrow fails to produce adequate numbers of peripheral blood elements.
Anemia, Diamond-Blackfan
A rare congenital hypoplastic anemia that usually presents early in infancy. The disease is characterized by a moderate to severe macrocytic anemia, occasional neutropenia or thrombocytosis, a normocellular bone marrow with erythroid hypoplasia, and an increased risk of developing leukemia. (Curr Opin Hematol 2000 Mar;7(2):85-94)
Drug-Induced Aplastic Anemia
A state of bone marrow suppression and failure that is caused by a cytotoxic or adverse immunologic response to a drug treatment, leading to a failure of production of red blood cells, white cells and platelets.
Fanconi Anemia
Congenital disorder affecting all bone marrow elements, resulting in ANEMIA; LEUKOPENIA; and THROMBOPENIA, and associated with cardiac, renal, and limb malformations as well as dermal pigmentary changes. Spontaneous CHROMOSOME BREAKAGE is a feature of this disease along with predisposition to LEUKEMIA. There are at least 7 complementation groups in Fanconi anemia: FANCA, FANCB, FANCC, FANCD1, FANCD2, FANCE, FANCF, FANCG, and FANCL. (from Online Mendelian Inheritance in Man, http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=227650, August 20, 2004)
Idiopathic Aplastic Anemia
Aplastic anemia without a known cause.
Myelophthisis
A condition resulting from the destruction of bone marrow precursor cells and their stroma. Bone marrow is displaced by fibrosis, tumors, or granulomas.
Pancytopenia
Deficiency of all three cell elements of the blood, erythrocytes, leukocytes and platelets.
Shwachman-Diamond Syndrome
An inherited syndrome characterized by EXOCRINE PANCREATIC INSUFFICIENCY; hematologic abnormalities (e.g., bone marrow hypoplasia), and skeletal abnormalities (e.g., metaphyseal chondroplasia). GERMLINE MUTATIONS in the SBDS gene are associated with Shwachman-Diamond Syndrome.
About the D61 Code Range
Aplastic anemias and other bone marrow failure syndromes appear here. The categories distinguish named forms from those linked to drugs or other external agents.
D61.0 groups constitutional forms, with subdivisions for pure red blood cell aplasia, Shwachman-Diamond syndrome, Fanconi anemia, and other forms. D61.1 identifies drug-induced aplastic anemia, while D61.2 identifies aplastic anemia due to other external agents. D61.3 identifies idiopathic aplastic anemia, and D61.9 is unspecified.
Under D61.8, pancytopenia splits by chemotherapy, other drugs, or other cases. Myelophthisis and other specified forms have separate subdivisions.
Questions About This Page
How many billable codes are in the D61 range?
Of the 17 codes in this range, 13 are billable and valid for claim submission from October 1, 2026 through September 30, 2027. Category header codes group them but cannot be reported on claims.
What does the D61 range classify?
The range classifies other aplastic anemias and other bone marrow failure syndromes. Each code links to its own reference page with billing status, MS-DRG grouping, coding notes, and clinical information.
Related References
Source: CMS FY 2027 ICD-10-CM Tabular List and order file, effective October 1, 2026 through September 30, 2027.
